The Dual Function of RhoGDI2 in Immunity and Cancer

por Tripathi, Mudrika, Colige, Alain, Deroanne, Christophe F.
Publicado 2023

Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment

por Brohée, Laura, Demine, Stéphane, Willems, Jérome, Arnould, Thierry, Colige, Alain C., Deroanne, Christophe F.
Publicado 2015

Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression

por Brohée, Laura, Peulen, Olivier, Nusgens, Betty, Castronovo, Vincent, Thiry, Marc, Colige, Alain C., Deroanne, Christophe F.
Publicado 2018

RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis

por Giang Ho, T. T., Stultiens, Audrey, Dubail, Johanne, Lapière, Charles M., Nusgens, Betty V., Colige, Alain C., Deroanne, Christophe F.
Publicado 2011

ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis

por Dupont, Laura, Joannes, Loïc, Morfoisse, Florent, Blacher, Silvia, Monseur, Christine, Deroanne, Christophe F., Noël, Agnès, Colige, Alain C.M.A.
Publicado 2022

Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents

por Mineur, Pierre, Colige, Alain C., Deroanne, Christophe. F., Dubail, Johanne, Kesteloot, Frédéric, Habraken, Yvette, Noël, Agnès, Vöö, Stefan, Waltenberger, Johannes, Lapière, Charles M., Nusgens, Betty V., Lambert, Charles A.
Publicado 2007